Trials / Completed
CompletedNCT01332396
Drug Use Investigation for TYKERB Tablet (All Case Investigation)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 4,054 (actual)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Data on the safety and efficacy of TYKERB shall be collected from the patients in order to grasp the actual conditions of post-marketing use and assess background information on the patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lapatinib |
Timeline
- Start date
- 2009-06-01
- Primary completion
- 2017-03-13
- Completion
- 2017-03-13
- First posted
- 2011-04-11
- Last updated
- 2017-04-26
Source: ClinicalTrials.gov record NCT01332396. Inclusion in this directory is not an endorsement.